National Institute of Mental Health (NIMH) grants Philpot and Zylka an R01 to study drugs that regulate expression of the protein Ube3a.

December 2011 – Faculty members Ben Philpot and Mark Zylka received a dual-PI R01 grant from the National Institute of Mental Health (NIMH) to study drugs that regulate expression of Ube3a, a ubiquitin protein ligase that is mutated in Angelman syndrome.